At this stage there is no premium from their offer to market which wasn't the case with their first offer - it is early days but perhaps this is it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025